The Henrietta Lacks Story and Eggs, Money and Motherhood
By David Jensen,
California Stem Cell Report
| 08. 07. 2013
[Quotes CGS's Diane Tober]
The legacy of Henrietta Lacks popped up again today in a piece in the New York Times that should resonate among stem cell researchers and within the stem cell industry.
It even has a current hook involving California legislation to permit women to sell their eggs for the purposes of scientific research – a bill that is now on the desk of Gov. Jerry Brown.
The issues in the Lacks saga involve ownership of human cells, trafficking in them and informed consent, all of which surface in one form or another in the state legislation.
But first a refresher on Henrietta Lacks. She was an African-American woman who died in 1951 of cervical cancer at the age of 31. Shortly before her death, physicians removed some of her tumor cells, and, as recounted in
today's NYTimes article by Carl Zimmer,
“They later discovered that the cells could thrive in a lab, a feat no human cells had achieved before.
"Soon the cells — nicknamed HeLa cells — were being shipped from Baltimore around the world. In the 62 years since...
Related Articles
By Caroline Kitchener, The New York Times | 08.21.2025
Less than two weeks after an Alabama Supreme Court decision upended in vitro fertilization in the state and prompted a national backlash, over 100 conservative congressional staff members and I.V.F. skeptics crammed into a meeting room a few blocks from...
By Carter Sherman, The Guardian | 08.23.2025
For Erica L and her husband, in-vitro fertilization was the “nuclear option”.
After two years of trying to conceive, Erica and her husband had no idea why they could not have a baby. Doctors said only that they had “unexplained...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Riley Beggin and Jeff Stein, The Washington Post | 08.03.2025
The White House does not plan to require health insurers to provide coverage for in vitro fertilization services, two people with knowledge of internal discussions said, even though the idea was one of President Donald Trump’s key campaign pledges.
Last...